NCT07043608 2025-07-02
ZAMBONI
University of California, San Francisco
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT02616744 2019-10-22
BONADIUV
Azienda Ospedaliero-Universitaria Careggi
Phase 2 Completed
NCT00478270 2017-08-16
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.
Hoffmann-La Roche
Phase 2 Withdrawn
NCT00502736 2014-01-22
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
Hoffmann-La Roche
Phase 2 Completed
NCT00381368 2006-12-04
Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
University of Turku
Phase 2 Unknown